Clinical Trials Browser

OTHER × Advanced Ovarian Cancer × Antineoplastic Agents × Clear all

NCT03611179 2018-08-02

Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer

Phase 2 Unknown

Advanced Ovarian Cancer